Cumulus

www.cumulusneuro.com/ www.linkedin.com/company/cumulusneuroscience/mycompany/

Cumulus Neuroscience provides a reliable real-world multimodal digital data acquisition and analytics platform and end-to-end services and solutions for CNS clinical trials. Our platform is designed to be the goldstandard for CNS assessments, providing the critical data and insight needed for faster, more robust and cost-effective clinical trials that improve the delivery of new therapies to patients. We provide frequent at-home acquisition, combining neurophysiological monitoring (EEG) time-linked with a range of assessment tools, including cognition, mood, language and sleep. The frequent remote assessment significantly lowers patient burden and allows aggregation of multiple sessions to account for dayto-day cognitive fluctuation. Cumulus was formed in collaboration with leading global pharmaceutical companies to meet the industry’s complex clinical trial needs with a pharma advisory consortium, and Cumulus’ platform is currently deployed in clinical trials for neurodegeneration and neuropsychiatric diseases.

Cumulus is a full-service digital data acquisition and analytic solutions provider with an at-home, real-world multimodal platform for use in CNS clinical trials. The flexible Cumulus platform allows frequent, low patient burden assessment of cognition, mood, language and sleep enabling sensitive and accurate patient monitoring and precision care.

Aman Bhatti Chief Executive Officer

+1 201 572 9409 aman@cumulusneuro.com

Shani Waninger

Vice President, Biopharma Business Development

+1 858 342 5044 shani@cumulusneuro.com